Pfizer raised the price of its Covid-19 vaccine by more than a quarter and Moderna by more than a tenth in the latest EU supply contracts as Europe battled supply disruptions and concerns about side effects from rival products.
在最新的歐盟供應合同中，輝瑞(Pfizer)將其新冠疫苗提價四分之一以上，而莫德納(Moderna)提價逾十分之一。目前歐洲正在艱難應對供應中斷和民衆對其他幾種疫苗副作用的擔憂。
您已閱讀17%（316字），剩餘83%（1516字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。